Back

Evidence-based ATTR-CM care in practice

29 August 2026 (13:05 - 13:25)
Organised by: Logo
Congress Presentation Part of: In focus: the next era of transthyretin amyloid cardiomyopathy (ATTR-CM) management European Society of Cardiology ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Olga Azevedo

Hospital Guimaraes, Guimaraes (Portugal)

4 More presentations in this session

Presentation thumbnail
Welcome and introductions
Professor S. Solomon (Boston, US)
Presentation thumbnail
Expert perspectives on the evolving ATTR-CM landscape
Professor R. Witteles (Stanford, US)
Presentation thumbnail
Contextualising ATTR-CM clinical trial designs
Professor S. Solomon (Boston, US)
Presentation thumbnail
Q&A and closing
Professor S. Solomon (Boston, US)

Access the full session

Session thumbnail
In focus: the next era of transthyretin amyloid cardiomyopathy (ATTR-CM) management

The Event

Event poster

ESC Congress 2026

29 August 2026 13:05 CET
You may be interested in
thumbnail
Congress Session
ATTRibutes of change: advances in treating and monitoring ATTR-CM
17 May 2025
thumbnail
Congress Presentation
Transthyretin-directed antisense oligonucleotide therapy effects on ATTRv myocardiopathy
20 May 2023
thumbnail
Congress Session
Evolving treatment paradigms in heart failure: from SGLT2 inhibition to transthyretin stabilisation and beyond
20 May 2025
thumbnail
Congress Session
Where evidence meets experience: redefining ATTR-CM treatment expectations
30 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources